NO170691C - Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav - Google Patents

Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav

Info

Publication number: NO170691C
Authority: NO; Norway
Prior art keywords: oncophetal; monoclonal antibodies; specific monoclonal; specific; antibodies
Prior art date: 1984-11-21

Application number

NO862920A

Other languages

English (en)

Other versions

NO862920L (no

NO170691B (no

NO862920D0 (no

Inventor

Joseph H Coggin Jr

William J Payne Jr

Original Assignee

Univ South Alabama

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-11-21

Filing date

1986-07-18

Publication date

1992-11-18

1986-07-18 Application filed by Univ South Alabama filed Critical Univ South Alabama

1986-07-18 Publication of NO862920L publication Critical patent/NO862920L/no

1986-07-18 Publication of NO862920D0 publication Critical patent/NO862920D0/no

1992-08-10 Publication of NO170691B publication Critical patent/NO170691B/no

1992-11-18 Publication of NO170691C publication Critical patent/NO170691C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Cell Biology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Optics & Photonics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

NO862920A 1984-11-21 1986-07-18 Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav NO170691C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/673,794 US4686180A (en)	1984-11-21	1984-11-21	Onco-fetal specific monoclonal antibodies, methods of preparation and use
PCT/US1985/002258 WO1986003223A1 (en)	1984-11-21	1985-11-15	Onco-fetal specific monoclonal antibodies, methods of preparation and use

Publications (4)

Publication Number	Publication Date
NO862920L NO862920L (no)	1986-07-18
NO862920D0 NO862920D0 (no)	1986-07-18
NO170691B NO170691B (no)	1992-08-10
NO170691C true NO170691C (no)	1992-11-18

Family

ID=24704144

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO862920A NO170691C (no)	1984-11-21	1986-07-18	Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav

Country Status (9)

Country	Link
US (1)	US4686180A (no)
EP (1)	EP0203967B1 (no)
JP (1)	JPH0683666B2 (no)
AU (1)	AU593229B2 (no)
CA (1)	CA1307218C (no)
DE (1)	DE3583296D1 (no)
FI (1)	FI92222C (no)
NO (1)	NO170691C (no)
WO (1)	WO1986003223A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4675287A (en) *	1984-07-26	1987-06-23	Scripps Clinic And Research Foundation	Monoclonal antibody directed to human ganglioside GD2
FR2571146B1 (fr) *	1984-10-01	1988-02-26	Centre Nat Rech Scient	Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5320941A (en) *	1986-06-06	1994-06-14	Dallan Young	DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPH0859089A (ja) *	1994-08-18	1996-03-05	Towa Kogyo Kk	ボビン搬送用トレイ
DE69739423D1 (de)	1996-04-05	2009-07-09	Univ South Alabama	Verwendung von onkofötal-antigen spezifischen cd4, cd8 zytotoxischen, suppressor t-zellen und interleukin-10
US20030124125A1 (en) *	1996-04-05	2003-07-03	South Alabama Medical Science Foundation	Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
DE10346627A1 (de) *	2003-10-08	2005-05-19	Weiss, Stefan, PD Dr.	Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung
GB0510790D0 (en)	2005-05-26	2005-06-29	Syngenta Crop Protection Ag	Anti-CD16 binding molecules
US20070048795A1 (en) *	2005-08-26	2007-03-01	Xiangming Fang	Immunoaffinity separation and analysis compositions and methods
WO2022161314A1 (zh)	2021-01-27	2022-08-04	信达生物制药(苏州)有限公司	针对cd16a的单域抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4440863A (en) *	1978-02-22	1984-04-03	Duke University	Breast cyst fluid protein assay
US4272504A (en) *	1978-12-14	1981-06-09	Abbott Laboratories	Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) *	1979-11-21	1982-09-14	The Wistar Institute	Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0072902B1 (de) *	1981-08-21	1985-04-24	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
JPH0811075B2 (ja) *	1982-06-30	1996-02-07	雄治松岡	単クローン性抗ｃｅａ抗体

1984
- 1984-11-21 US US06/673,794 patent/US4686180A/en not_active Expired - Lifetime
1985
- 1985-11-15 JP JP60505335A patent/JPH0683666B2/ja not_active Expired - Lifetime
- 1985-11-15 EP EP85906109A patent/EP0203967B1/en not_active Expired - Lifetime
- 1985-11-15 AU AU51964/86A patent/AU593229B2/en not_active Ceased
- 1985-11-15 WO PCT/US1985/002258 patent/WO1986003223A1/en active IP Right Grant
- 1985-11-15 DE DE8585906109T patent/DE3583296D1/de not_active Expired - Lifetime
- 1985-11-20 CA CA000495803A patent/CA1307218C/en not_active Expired - Fee Related
1986
- 1986-07-18 FI FI862978A patent/FI92222C/fi not_active IP Right Cessation
- 1986-07-18 NO NO862920A patent/NO170691C/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO1986003223A1 (en)	1986-06-05
JPS62501189A (ja)	1987-05-14
DE3583296D1 (de)	1991-07-25
US4686180A (en)	1987-08-11
AU5196486A (en)	1986-06-18
JPH0683666B2 (ja)	1994-10-26
FI862978A (fi)	1986-07-18
EP0203967B1 (en)	1991-06-19
EP0203967A4 (en)	1987-04-10
FI92222B (fi)	1994-06-30
CA1307218C (en)	1992-09-08
FI862978A0 (fi)	1986-07-18
NO862920L (no)	1986-07-18
NO170691B (no)	1992-08-10
EP0203967A1 (en)	1986-12-10
NO862920D0 (no)	1986-07-18
AU593229B2 (en)	1990-02-08
FI92222C (fi)	1994-10-10

Publication	Publication Date	Title
DK666389D0 (da)	1989-12-22	Monoklonalt antistof
DK401583A (da)	1984-03-04	Parenkymal celle-cellulose og beslaegtede materialer
DK47285A (da)	1985-08-04	Renininhiberende peptider og anvendelsen deraf
DK391785D0 (da)	1985-08-29	Monoklonale antistoffer samt deres fremstilling og anvendelse
EP0240344A3 (en)	1989-08-16	Monoclonal antibodies and their use
DK63187A (da)	1987-08-08	Krydsbeskyttende monoklonale antistofpraeparater
DK557383A (da)	1984-06-04	Monoclone antistoffer og deres anvendelse
DE3689948D1 (de)	1994-08-11	Monoklonale antikörper und testverfahren.
DK188185D0 (da)	1985-04-26	Monoklonalt antistof
NO170691C (no)	1992-11-18	Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav
EP0285511A3 (en)	1988-12-28	Monoclonal antibodies and their uses
NO177311C (no)	1995-08-23	Anti-fucosylceramid monoklonalt antistoff
DE3587714D1 (de)	1994-02-17	Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DK717888A (da)	1989-06-25	Monoklonale antistoffer
DK37785D0 (da)	1985-01-28	Monoclonalt antistof
DK144485D0 (da)	1985-03-29	Monoklonale antistoffer
DK474189A (da)	1990-03-28	Monoklonalt antistof
DK413389D0 (da)	1989-08-22	Monoklonale antistoffer
DK370089A (da)	1990-02-13	Anti-urokinase monoklonale antistoffer
DK325183D0 (da)	1983-07-14	Mumane monoclonale antistoffer og lymfokiner
DK240286A (da)	1986-11-24	Monoklonale antistoffer
FI923418A0 (fi)	1992-07-29	Monoklonaalinen vasta-aine
IT1194260B (it)	1988-09-14	Linfochine e anticorpi monoclonali umani
GB8432502D0 (en)	1985-02-06	Monoclonal antibody
DK220688D0 (da)	1988-04-22	Monoklonalt antistof

Legal Events

Date	Code	Title	Description
2003-06-30	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN MAY 2003